Quants Research Institute Holdings, Inc. · TSE:9552
Quants Research Institute — Q2 FY2026/9 Earnings Presentation
48 slides from Quants Research Institute's earnings presentation, May 15, 2026
Slide 1: FY2026/9 Q2 Financial Results Presentation
FY2026/9 Q2 Financial Results Presentation May 15, 2026 Quants Research Institute Holdings, Inc. (TSE Prime: 9552)
Slide 2: Table of Contents
Table of Contents 1 FY 2026/9 Q2 Earnings Results 2 FY 2026/9 Earnings Forecast 3 Medium-to Long-term Growth Strategy 4 Q&A 5 Company Overview 6 Business Overview and Competitive Advantages 7 Reference Copyright © 2026 Quants Research Institute HD. All rights reserved. Highly Confidential to Quants
Slide 3: Consolidated: Earnings Summary (IFRS)
1. FY2026/9 Q2 Earnings Results Consolidated: Earnings Summary (IFRS) (Unit: Million yen) FY26/9 1 FY26/9 Q2 Progress Rate FY25/9 Q2 YoY (Forecast) Net Sales 22,292 10,296 46.2％ 7,658 ＋34.4％ M&A Brokerage 18,000 8,523 47.4％ 7,095 +20.1％ Consulting Business 3,800 1,658 43.6% 563 ＋194.2% 2 Incubation
Slide 4: Consolidated: Highlights by Segment (IFRS)
1. FY2026/9 Q2 Earnings Results Consolidated: Highlights by Segment (IFRS) Net Sales Composition by Segment Financial Highlight Services for Large Enterprises Incubation 114 Consulting Business Consulting Business (-) • Net sales amounted to ¥1,658 million (up 194.2% YoY), reflecting steady progress
Slide 5: M&A Brokerage: Financial Highlight (Quarterly Accounting Period)
1. FY2026/9 Q2 Earnings Results M&A Brokerage: Financial Highlight (Quarterly Accounting Period) The decline of ongoing deals is attributable to the continued application of stricter criteria for assessing deal completion prospects. We will continue to rigorously manage our deal portfolio with a foc
Slide 6: M&A Brokerage: Trends of Key Metrics over the Past Three Years
1. FY2026/9 Q2 Earnings Results M&A Brokerage: Trends of Key Metrics over the Past Three Years The number of closed deals increased by 6 YoY, and the contribution from large deals led to net sales of ¥4,583 million. We continue to implement initiatives to improve the closing rate; however, it will t
Slide 7: M&A Brokerage: Quarterly Headcount Trend
1. FY2026/9 Q2 Earnings Results M&A Brokerge: Quarterly Headcount Trend While maintaining our overall hiring policy, we are further enhancing the use of AI—an initiative we have been advancing—to improve operational efficiency and increase productivity per employee, while securing talent to support
Slide 8: M&A Brokerage: Reassessment of Strategy
1. FY2026/9 Q2 Earnings Results M&A Brokerage: Reassessment of Strategy Previously, we had assumed high growth driven by DX and AI utilization together with headcount expansion. However, changes in the market environment increased deal execution difficulty, resulting in a mismatch with the pace of h
Slide 9: Consulting Business: Trends in Key Metrics
1. FY2026/9 Q2 Earnings Results Consulting Business: Trends in Key Metrics Net sales reached ¥934 million (+173.9% YoY), broadly in line with expectations. The utilization rate has remained at approximately 90%. As net sales are structurally linked to the number of consultants, we expect a gradual i
Slide 10: Consulting Business: Track Record
1. FY2026/9 Q2 Earnings Results Consulting Business: Track Record At present, we have not seen any decline in consulting demand or restraint in investment by clients due to the impact of AI. Among our clients, particularly large enterprises, AI investment is accelerating, and we expect related proje
Slide 11: Consulting Business: Establishment of AI Lab
1. FY2026/9 Q2 Earnings Results Consulting Business: Establishment of AI Lab In response to growing demand, we established an in-house AI lab to develop AI expert talent. Positioning the fiscal year ending September 2026 as a preparation phase, we aim to become a consulting firm with significant org
Slide 12: Consolidated: Balance Sheet (IFRS)
1. FY2026/9 Q2 Earnings Results Consolidated: Balance Sheet (IFRS) In FY25/9, we enhanced shareholder returns through share repurchases, treasury share cancellation, and dividend payments. We will continue to balance capital efficiency improvement with growth investments. In the operating lease busi
Slide 13: Acquisition of Own Shares
1. FY2026/9 Q2 Earnings Results Acquisition of Own Shares We believe that the current share price does not fully reflect the Company’s future profitability. Based on this view, we decided to conduct a share repurchase to enhance shareholder returns and improve capital efficiency. Overview of Own Sha
Slide 14: 2 FY 2026/9 Earnings Forecast
Table of Contents 1 FY 2026/9 Q2 Earnings Results 2 FY 2026/9 Earnings Forecast 3 Medium-to Long-term Growth Strategy 4 Q&A 5 Company Overview 6 Business Overview and Competitive Advantages 7 Reference Copyright © 2026 Quants Research Institute HD. All rights reserved. Highly Confidential to Quants
Slide 15: Consolidated: Earnings Forecast (IFRS)
2. FY 2026/9 Earnings Forecast Consolidated：Earnings Forecast (IFRS) We have revised our consolidated earnings forecast following the change in the full-year forecast for the Incubation. (Unit: Million yen) 1 FY25/9 Actual FY26/9 Initial Plan YoY Growth Net Sales 16,602 revision 22,184 → 22,292 +34.
Slide 16: M&A Brokerage: Earnings Forecast (IFRS)
2. FY 2026/9 Earnings Forecast M&A Brokerage: Earnings Forecast (IFRS) We are implementing department-specific initiatives, including a structure in which department heads directly manage transactions and measures to improve matching accuracy, to drive company-wide growth. Although advisor hiring pl
Slide 17: Consulting Business: Earnings Forecast (IFRS)
2. FY 2026/9 Earnings Forecast Consulting Business: Earnings Forecast (IFRS) We will continue to actively recruit consultants. For the current fiscal year, taking workforce expansion into account, we anticipate a utilization rate of approximately 90%. In addition, we are making strategic investments
Slide 18: Incubation: Earnings Forecast (IFRS)
2. FY 2026/9 Earnings Forecast 1 Incubation : Earnings Forecast (IFRS) We have obtained the licenses required for the operating lease business and have started product sales. We are currently in the sourcing phase for product origination, with origination amounts to be determined based on business p
Slide 19: 3 Medium-to Long-term Growth Strategy
Table of Contents 1 FY 2026/9 Q2 Earnings Results 2 FY 2026/9 Earnings Forecast 3 Medium-to Long-term Growth Strategy 4 Q&A 5 Company Overview 6 Business Overview and Competitive Advantages 7 Reference Copyright © 2026 Quants Research Institute HD. All rights reserved. Highly Confidential to Quants
Slide 20: Launching New Business
3. Medium-to Long-term Growth Strategy Launching New Business Using the stable cash flow generated from our existing business (M&A brokerage business) as a funding source, we are investing in new businesses to cultivate future net sales pillars over the medium to long term. As these new businesses g
Slide 21: M&A Brokerage: Initiatives to Increase Net Sales
3. Medium-to Long-term Growth Strategy M&A Brokerage: Initiatives to Increase Net Sales Strategic initiatives are being implemented for each department. Sales Department(Direct Sales Model) will address current challenges by enhancing management and the quality of training. Financial Institution Par
Slide 22: M&A Brokerage: Expansion of Offices
3. Medium-to Long-term Growth Strategy M&A Brokerage: Expansion of Offices Expanding domestic and international offices to strengthen the sales structure. Successful track records in projects involving [Domestic Companies× Foreign Companies], as well as [Foreign Companies × Foreign Companies] have b
Slide 23: Consulting Business: Growth Strategy
3. Medium-to Long-term Growth Strategy Consulting Business: Growth Strategy While continuing active hiring, we are expanding the organization around members with management experience at major consulting firms. We aim to achieve steady and sustainable growth with a strong focus on quality. Competiti
Slide 24: Dividend Payment
3. Medium-to Long-term Growth Strategy Dividend Payment We aim to build long-term trust with shareholders through balanced shareholder returns and market-conscious management. We remain in a growth phase and will continue disciplined, proactive investments to achieve both sustainable growth and prof
Slide 25: 4 Q&A
Table of Contents 1 FY 2026/9 Q2 Earnings Results 2 FY 2026/9 Earnings Forecast 3 Medium-to Long-term Growth Strategy 4 Q&A 5 Company Overview 6 Business Overview and Competitive Advantages 7 Reference Copyright © 2026 Quants Research Institute HD. All rights reserved. Highly Confidential to Quants
Slide 26: Frequently Asked and Anticipated Questions
4. Q&A Frequently Asked and Anticipated Questions Category Q A The number of new deals has increased compared with the first quarter, and we believe that stronger management involvement and follow-up efforts are beginning to show positive effects. The slight decline in ongoing deals is attributable
Slide 27: Frequently Asked and Anticipated Questions
4. Q&A Frequently Asked and Anticipated Questions Category Q A The number of advisors declined as we continued to apply stricter hiring standards. At present, in addition to revising our hiring criteria, we are further What was the reason for the decline in the advancing the use of AI and transition
Slide 28: Frequently Asked and Anticipated Questions
4. Q&A Frequently Asked and Anticipated Questions Category Q A Net sales are structurally linked to the number of consultants, and we expect net sales to expand gradually throughout the fiscal year Progress against the full-year net sales as headcount increases. forecast stood at 43.6% as of the end
Slide 29: Frequently Asked and Anticipated Questions
4. Q&A Frequently Asked and Anticipated Questions Category Q A This is because, following discussions with our audit firm, we concluded that JOL products in the operating lease business are required to be recognized as assets on the consolidated balance sheet under IFRS. Why does the incubation busi
Slide 30: 5 Company Overview
Table of Contents 1 FY 2026/9 Q2 Earnings Results 2 FY 2026/9 Earnings Forecast 3 Medium-to Long-term Growth Strategy 4 Q&A 5 Company Overview 6 Business Overview and Competitive Advantages 7 Reference Copyright © 2026 Quants Research Institute HD. All rights reserved. Highly Confidential to Quants
Slide 31: About Our Company
5. Company Overview About Our Company Our group is a professional firm specializing in consulting business for large enterprises and M&A brokerage business for mid-sized and small companies. (TSE Prime: 9552) As a professional firm supporting the Japanese economy, we leverage data, technology, and q
Slide 32: Company Overview
5. Company Overview Company Overview Company Name Quants Research Institute Holdings, Inc. Corporate Philosophy As a professional firm supporting the Established October 12, 2018 Japanese economy, we leverage data, technology, and quantitative insights to Representative Shunsaku Sagami address socie
Slide 33: Directors & Auditors
5. Company Overview Directors & Auditors Akihiro Yabuki, Director Hiroki Kagami, Director & CFO Graduated from Meiji University. Joined Keyence Corporation in 2010, Graduated from Ritsumeikan University. Joined Aichi Bank in 2006, working engaging in consulting sales for the manufacturing sector. Jo
Slide 34: Governance Structure
5. Company Overview Governance Structure Independence and diversity have been emphasized in the governance framework, which has been further refined. Through rigorous risk management and compliance, along with transparent and proactive information disclosure, we seek to strengthen the foundation of
Slide 35: Our Strengths
5. Company Overview Our Strengths Our company is built on three core strengths, which we leverage to expand our business across multiple areas. Management & Talent System Organization Acquisition Development Institutionalize data-driven Attract top talent through systems All internal systems are ful
Slide 36: 6 Business Overview and Competitive Advantages
Table of Contents 1 FY 2026/9 Q2 Earnings Results 2 FY 2026/9 Earnings Forecast 3 Medium-to Long-term Growth Strategy 4 Q&A 5 Company Overview 6 Business Overview and Competitive Advantages 7 Reference Copyright © 2026 Quants Research Institute HD. All rights reserved. Highly Confidential to Quants
Slide 37: M&A Brokerage: Business Model
6. Business Overview and Competitive Advantages M&A Brokerage: Business Model We operate an intermediary business model that collects fees from both the seller and the buyer. By improving operational efficiency and reducing costs, we have adopted a fully success-based fee structure for sellers, with
Slide 38: M&A Brokerage: Service Advantages
6. Business Overview and Competitive Advantages M&A Brokerage: Service Advantages Pricing, speed to completing M&A transactions, and matching capability, creating a competitive advantage 1 Adopt a pricing system with only success fees Selling companies are charged with only a success fee 2 Average t
Slide 39: M&A Brokerage: Advantages in Recruitment
6. Business Overview and Competitive Advantages M&A Brokerage: Advantages in Recruitment We have created a working environment where M&A advisors can work efficiently concentrating on essential work by promoting systemization of other work with DX and AI technology. We also try to differentiate from
Slide 40: Consulting Business: Service Overview
6. Business Overview and Competitive Advantages Consulting Business: Service Overview Centered on members from major consulting firms, we focus on DX consulting while providing effective, results- driven solutions across a wide range of areas including strategy, organization, talent, and IT. Technol
Slide 41: 7 Reference
Table of Contents 1 FY 2026/9 Q1 Earnings Results 2 FY 2026/9 Earnings Forecast 3 Medium-to Long-term Growth Strategy 4 Q&A 5 Company Overview 6 Business Overview and Competitive Advantages 7 Reference Copyright © 2026 Quants Research Institute HD. All rights reserved. Highly Confidential to Quants
Slide 42: Consolidated: Financial Highlight (Quarterly Accounting Period)
7. Reference: KPI Highlights Consolidated: Financial Highlight (Quarterly Accounting Period) (Unit: Million yen) 1 FY23/9 FY24/9 FY25/9 FY26/9 (J-GAAP) (J-GAAP) (J-GAAP) (IFRS) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Net Sales 2,125 1,749 2,462 2,305 4,900 3,626 4,244 3,778 4,178 3,480 3,939 5,005
Slide 43: M&A Brokerage: Financial Highlight (Quarterly Accounting Period)
7. Reference: KPI Highlights M&A Brokerage: Financial Highlight(Quarterly Accounting Period) (Unit: Million yen) 1 FY23/9 FY24/9 FY25/9 FY26/9 (J-GAAP) (J-GAAP) (J-GAAP) (IFRS) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Net Sales 2,125 1,750 2,462 2,306 4,892 3,590 4,189 3,629 3,956 3,139 3,629 4,422
Slide 44: Consulting Business: Financial Highlight (Quarterly Accounting Period)
7. Reference: KPI Highlights Consulting Business: Financial Highlight (Quarterly Accounting Period) (Unit: Million yen) 1 FY24/9 FY25/9 FY26/9 (J-GAAP) (J-GAAP) (IFRS) Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Net Sales 7 35 55 149 222 341 306 581 723 934 Operating Profit -7 -71 -98 -46 -23 -76 -438 -204 -100 -
Slide 45: M&A Brokerage: Deal Flow by Step
7. Reference: M&A Brokerage Deal Flow by Step M&A Brokerage: Deal Flow by Step The M&A process is divided into three phases. At our company, two departments work in a specialized structure: the Sales Department (M&A Advisors) and the Corporate Sales Department (matching). By leveraging DX and AI to
Slide 46: M&A Brokerage: Track Record of Deal Closures
7. Reference: M&A Conclusion M&A Brokerage: Track Record of Deal Closures We have successfully brokered M&As with companies in various industries, sectors, and regions. Closed Deals (Examples) Business of Selling Companies1 Seller Buyer 1% 1％ 3% 1％ Manufacturing Business Description Region Business
Slide 47: Shareholder Composition
7. Reference: Shareholder Composition Shareholder Composition Change in Shareholder Composition Treasury Stock Treasury Stock Domestic Institutional 0.1％ Domestic Institutional 0.1％ Investors Investors 9.2% 10.0% Foreign Institutional Foreign Investors Institutional Investors 15.9% As of As of 16.4%
Slide 48: Disclaimer
Disclaimer The materials and information provided in this presentation include so-called “forward-looking statements.” These statements are based on current expectations, forecasts, and assumptions involving risks and uncertainties, and actual results may differ materially from those expressed or im
Quants Research Institute Holdings — Q2 FY2026/9 Earnings Presentation on 6ix